Impressive Continuous Complete Response after Mogamulizumab in a Heavily Pretreated Sézary Syndrome Patient

por Lolli, Ginevra, Casadei, Beatrice, Argnani, Lisa, Nanni, Laura, Cavo, Michele, Zinzani, Pier Luigi
Publicado 2020

BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience

por Stefoni, Vittorio, Argnani, Lisa, Carella, Matteo, Casadei, Beatrice, Morigi, Alice, Lolli, Ginevra, Broccoli, Alessandro, Pellegrini, Cinzia, Nanni, Laura, Coppola, Paolo Elia, Zinzani, Pier Luigi
Publicado 2022

Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma

por Casadei, Beatrice, Argnani, Lisa, Morigi, Alice, Lolli, Ginevra, Broccoli, Alessandro, Pellegrini, Cinzia, Nanni, Laura, Stefoni, Vittorio, Coppola, Paolo E., Carella, Matteo, Cavo, Michele, Zinzani, Pier Luigi
Publicado 2020

Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients

por Casadei, Beatrice, Argnani, Lisa, Morigi, Alice, Lolli, Ginevra, Broccoli, Alessandro, Pellegrini, Cinzia, Nanni, Laura, Stefoni, Vittorio, Coppola, Paolo Elia, Carella, Matteo, Cavo, Michele, Zinzani, Pier Luigi
Publicado 2020

ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study

por Giladi, Odil, Bagnato, Gianmarco, Gentilini, Marianna, Shimony, Shai, Pasvolsky, Oren, Berger, Tamar, Itchaki, Gilad, Raanani, Pia, Broccoli, Alessandro, Stefoni, Vittorio Stefoni, Lolli, Ginevra, Argnani, Lisa, Zinzani, Pier Luigi, Gurion, Ronit
Publicado 2022

Poster: ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study

por Giladi, Odil, Bagnato, Gianmarco, Gentilini, Marianna, Shimony, Shai, Pasvolsky, Oren, Berger, Tamar, Itchaki, Gilad, Raanani, Pia, Broccoli, Alessandro, Stefoni, Vittorio Stefoni, Lolli, Ginevra, Argnani, Lisa, Zinzani, Pier Luigi, Gurion, Ronit
Publicado 2022

Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience

por Casadei, Beatrice, Argnani, Lisa, Guadagnuolo, Serafina, Pellegrini, Cinzia, Stefoni, Vittorio, Broccoli, Alessandro, Nanni, Laura, Morigi, Alice, Lolli, Ginevra, Guarino, Maria, Spinardi, Luca, Pierucci, Elisabetta, Fanti, Stefano, Bartoletti, Michele, Dicataldo, Michele, Sabattini, Elena, Bonifazi, Francesca, Zinzani, Pier Luigi
Publicado 2021

Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy

por De Matteis, Serena, Casadei, Beatrice, Lolli, Ginevra, Dicataldo, Michele, Barbato, Francesco, Dan, Elisa, Paccagnella, Andrea, Sinigaglia, Barbara, Bertuzzi, Clara, Arcari, Annalisa, Zazzeroni, Luca, Bernuzzi, Patrizia, Laprovitera, Noemi, Storci, Gianluca, Bertuccio, Salvatore Nicola, Ferracin, Manuela, Bonafè, Massimiliano, Zinzani, Pier Luigi, Bonifazi, Francesca
Publicado 2022